164 related articles for article (PubMed ID: 7112992)
41. Pathogenesis of renal microvascular complications in diabetes mellitus.
Veldman BA; Vervoort G
Neth J Med; 2002 Nov; 60(10):390-6. PubMed ID: 12607589
[No Abstract] [Full Text] [Related]
42. [Zinc deficiency as a cause of dermatosis in a patient with type I diabetes and renal insufficiency].
Bouda M; Krízek M; Malkusová I; Motán J; Pizinger K; Rusavý Z
Vnitr Lek; 1994 Jul; 40(7):445-7. PubMed ID: 8073663
[No Abstract] [Full Text] [Related]
43. The diabetic patient with renal failure.
Ritz E; Schömig M
Nefrologia; 2000; 20 Suppl 3():16-24. PubMed ID: 10835873
[No Abstract] [Full Text] [Related]
44. A note on tolbutamide and diabetes.
Med Lett Drugs Ther; 1970 Jul; 12(14):60. PubMed ID: 4935987
[No Abstract] [Full Text] [Related]
45. The diabetic patient with renal insufficiency.
Vanhille P
Diabetes Metab; 2000 Jul; 26 Suppl 4():67-72. PubMed ID: 10922976
[TBL] [Abstract][Full Text] [Related]
46. [Doctors, diabetes and the danger of death].
de Looff AJ
Ned Tijdschr Geneeskd; 1977 Dec; 121(49):1945-8. PubMed ID: 412111
[No Abstract] [Full Text] [Related]
47. Letter: Phenylbutazone-tolbutamide drug interaction.
Tannenbaum H; Anderson LG; Soeldner JS
N Engl J Med; 1974 Feb; 290(6):344. PubMed ID: 4809290
[No Abstract] [Full Text] [Related]
48. Acute pulmonary oedema occurring in association with diabetic ketoacidosis in a diabetic patient with chronic renal failure.
Catalano C; Fabbian F; Di Landro D
Nephrol Dial Transplant; 1998 Feb; 13(2):491-2. PubMed ID: 9509471
[No Abstract] [Full Text] [Related]
49. [Hypoglycemic sulfonamides, kidney failure and hypoglycemic coma].
Akoun G; Beucler A; Pignard P
Cah Med; 1974 Jun; 15(6):333-6. PubMed ID: 4447668
[No Abstract] [Full Text] [Related]
50. [Tolbutamide and coronary heart disease].
Paasikivi J
Duodecim; 1971; 87(21):1405-8. PubMed ID: 5114598
[No Abstract] [Full Text] [Related]
51. [Protracted hypoglycemia as a consequence of the secret taking of glibenclamide by a young female diabetic].
Born P; Neuhaus H; Eimiller A; Paul F
Dtsch Med Wochenschr; 1986 Nov; 111(46):1780-1. PubMed ID: 3096683
[No Abstract] [Full Text] [Related]
52. The tolbutamide Controversy: a personal perspective.
Schwartz TB
Ann Intern Med; 1971 Aug; 75(2):303-6. PubMed ID: 5558655
[No Abstract] [Full Text] [Related]
53. Successful appetite suppression therapy with fenfluramine and phentermine in the obese diabetic transplant patient.
Khan M; Lum CT; Rao V
Transplant Proc; 1995 Feb; 27(1):975-6. PubMed ID: 7879251
[No Abstract] [Full Text] [Related]
54. [Long duration of neonatal hypoglycemia with chlorpropamide treated diabetic mothers].
Tidsskr Nor Laegeforen; 1970 Jan; 90(1):36. PubMed ID: 5426187
[No Abstract] [Full Text] [Related]
55. Tolbutamide (Orinase) and diabetes.
Med Lett Drugs Ther; 1970 Nov; 12(24):97-8. PubMed ID: 5514167
[No Abstract] [Full Text] [Related]
56. [Advantages of insulin Lispro (short-acting) in terminal kidney failure].
Jehle PM; Aisenpreis U; Bundschu D; Keller F
Fortschr Med; 1999 Apr; 117(11):41-2. PubMed ID: 10339922
[TBL] [Abstract][Full Text] [Related]
57. The tolbutamide controversy.
Compr Ther; 1975 May; 1(1):19-20. PubMed ID: 1222531
[No Abstract] [Full Text] [Related]
58. Estimating glomerular filtration rate might help to avoid hypoglycemia.
Corsonello A; Pedone C; Corica F; Mazzei B; Mari V; Incalzi RA
J Am Geriatr Soc; 2006 Sep; 54(9):1469-70. PubMed ID: 16970663
[No Abstract] [Full Text] [Related]
59. [Kidney transplantation in patients with type I and type II diabetes mellitus].
Baptista C; Bastos M; Gomes L; Macário F; Ruas L; Rodrigues D; Alves R; Gomes H; Ferreira C; Roseiro A; Paiva S; Barros L; Carvalheiro M; Mota A; Furtado AL; Ruas MM
Acta Med Port; 1998 Nov; 11(11):943-6. PubMed ID: 10021792
[TBL] [Abstract][Full Text] [Related]
60. Tolbutamide photosensitivity.
Kar PK; Das Gupta SK; Das KD
J Indian Med Assoc; 1984 Aug; 82(8):289-91. PubMed ID: 6491339
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
